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Atherosclerosis is one of the leading causes of
morbidity and mortality in the world. Rupture of
atherosclerotic plaques and formation of thrombi are
the primary mechanisms of myocardial infarction or
cerebrovascular accidents. Atherosclerosis is therefore
a dynamic inflammatory disorder and the biological
composition and inflammatory state of an atheroscle-
rotic plaque, rather than the degree of stenosis or its
size, are the major determinants of acute clinical
events [1, 2]. Noninvasive techniques to detect
vulnerable atherosclerotic plaque are critically
needed. In recent years, radionuclide imaging [3–6],
magnetic resonance imaging (MRI) [7–13], and com-
puted tomography (CT) have been put forward as the
most relevant imaging modalities to identify athero-
sclerotic vascular disease and the vulnerable plaque
[14–30]. Positron emission tomography with fluoro-
deoxyglucose (FDG-PET) has become one of the
advanced imaging approaches for the detection of
vulnerable plaques [31]. Ogawa et al. [32] showed that
macrophages are responsible for the accumulation of
FDG in atherosclerotic lesions whereby FDG uptake is
correlated with macrophage density. Because vulner-
able plaques are rich in macrophages, FDG imaging
should be useful for selective detection of such
plaques. In recent years, multislice CT has been shown
to provide excellent anatomical and morphological
images both of the large vessels and the coronary
arteries [18]. In addition, differences in plaque com-
position and distribution—both in acute coronary
syndromes and stable coronary artery disease—can
adequately be visualized with multislice-CT [29, 30].
Hybrid imaging with both PET and CT, being a
combined functional and structural whole-body imaging
modality, could therefore offer the optimal potential
to characterize plaque composition [33, 34]. Tatsumi
et al. [35] showed in 85 patients who underwent FDG
PET/CT imaging that FDG uptake was commonly
depicted in the thoracic aortic wall. The FDG uptake
site was mostly distinct from the calcification site and
was located in areas of metabolic activity (i.e.,
macrophages) of atherosclerotic changes. Ben-Haim
et al. [36] evaluated FDG uptake in atherosclerotic
plaques in 50 asymptomatic patients. Repeat PET/CT
studies were performed to assess changes in patterns
of FDG uptake and CT calcifications. FDG-avid foci
represent a dynamic process of transient inflamma-
tion, whereas CT calcifications indicate stable
atherosclerosis. Hybrid imaging with PET/CT creates
therefore incremental value over both imaging
modalities alone. Rudd et al. [37] showed that
atherosclerosis imaging with FDG-PET/CT was
useful for tracking inflammation within plaques.
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The authors assessed the short-term reproducibility
of PET/CT in peripheral artery disease. Twenty
patients with vascular disease underwent PET/CT
imaging of the iliac, femoral, and carotid arteries
90 min after FDG administration. Mean and
maximum target-to-background ratios in the carotid,
iliac, and femoral arteries were highly reproducible.
It was suggested that mean target-to-background ratio
could be used for tracking systemic arterial therapies,
whereas the maximum target-to-background ratio
proved to be optimal for detecting and monitoring
local, plaque-based therapy.
In the present issue of the International Journal of
Cardiovascular Imaging, Wasselius et al. [38]
assessed atherosclerotic plaques in a large asymp-
tomatic population stratified to age and sex. The
authors analyzed 200 patients in four age-groups of
20–30, 40–50, 60–70 and 80–90 years old, who were
referred for whole-body FDG-PET/CT-examination.
Uptake of FDG in active, calcified inactive and mixed
atherosclerotic plaques was assessed in eight defined
vessel segments. There was a high correlation
between the total number of cardiovascular risk
factors and the number of FDG-accumulating active
plaques as well as the number of CT-determined
calcified inactive plaques. A significant difference in
the number of plaques between all age-groups was
observed except for active plaques in the age groups
of 60–70 and 80–90 years. A remarkable finding was
that mixed plaques were very rare, similar to previous
findings [39], suggesting that plaque inflammation
and calcification are indeed discrete temporal patho-
physiological entities. In addition, high counts for
active plaques generally were paralleled by high
counts for inactive, calcified plaques. Furthermore, a
decrease in the number of active plaques was also
accompanied by decreases in inactive, calcified
plaques. This finding suggests that the lesions
detected in the walls of large arteries by FDG-PET
represent inflammation associated with the early
phases of atherosclerosis. Lastly, statin-treatment
was associated with a significantly lower number of
active plaques. Consequently, FDG-PET/CT imaging
was able to assess total plaque burden of patients, to
identify plaque composition, and to monitor medical
treatment of inflamed atherosclerotic plaques.
In a recent study by the same group [40], it was
shown that graft infection was a serious complication
to vascular surgery. FDG uptake was assessed in
vascular grafts in 2,045 patients with or without
symptoms of graft infection. Of all 2,045 patients
examined by PET/CT, 16 patients with synthetic
aortic grafts were identified and reevaluated for FDG
accumulation. High FDG uptake was found in 10 of
12 grafts in the patients who underwent open surgery
and in one of four grafts in patients who underwent
endovascular aneurysm repair. Uptake of FDG in
vascular grafts was found in the vast majority of
patients without graft infection, even a long time after
surgery. The basis for the FDG accumulation could
be the chronic inflammation known to occur on the
surface of synthetic graft material. Accumulation of
FDG appeared to be less prominent in endovascular
grafts than in conventional grafts.
In summary, integrated PET/CT imaging is a
powerful new noninvasive modality that offers the
potential for refined diagnosis and management of the
entire spectrum of cardiovascular atherosclerosis
[41]. Using PET/CT imaging, plaque inflammation
(active plaques) and calcification (inactive plaques)
can be observed as discrete temporal pathophysio-
logical entities. Combined PET/CT imaging may
therefore be superior to the single use of both PET
imaging and CT angiography in guiding pharmaco-
logical treatment, assisting in revascularization
decisions, and evaluating therapeutic effects.
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